Compass Pathways (NASDAQ:CMPS) said new 26-week data from its Phase 3 COMP006 trial further support the durability and safety ...
Compass Pathways has announced six‑month results from its second phase 3 trial of COMP360, its synthetic formulation of ...
Phase 3 COMP006 trial results demonstrate that COMP360, an investigational synthetic psilocybin formulation, provides a rapid and durable clinical benefit through 6 months in patients with chronic ...
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the 26-week results (Part B) from its second ongoing ...
Timeslife on MSN
How monarch butterflies use the sun as a compass to navigate 4,000 kilometres of migration
A Clock Inside the Antenna The monarch butterfly does not simply fly toward the sun. That would leave it hopelessly off ...
Mayo Clinic is being sued by a former research director over allegations she was retaliated against—and ultimately terminated ...
The University of Kentucky's legal counsel said certain regulations require its administrators to make international trips.
The Trump administration plans to open a 528-bed holding facility for migrant families and unaccompanied children next to an ...
After suffering the loss of her child, journalist Esme Saleh leaned into her creative side, painting folk art-inspired taper ...
The Attorney General and Commissioner for Justice of Borno State, Hauwa Abubakar, tells OGHENOVO EGODO-MICHAEL about her career journey As one of the few women to serve as Attorney General and ...
Gov. Josh Shapiro this week announced Pennsylvania is ranked 13th by CNBC in its America’s Top States for Business 2026 ...
Mayo Clinic's former director of research operations is suing the health system, alleging that she was pushed out of her role ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results